PB2183: RELAPSE PREDICTS POOR OUTCOMES IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

PB2183: RELAPSE PREDICTS POOR OUTCOMES IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

Bibliographic Details
Main Authors:	E. Gavriilaki, A. Papalexandri, D. Mallouri, I. Batsis, A. Vardi, Z. Bousiou, C. Demosthenous, A. Panteliadou, N. Spyridis, G. Karavalakis, T. Touloumenidou, M. Masmanidou, G. Pistiolas, F. Mouladeniou, C. Vadikoliou, C. Lalayanni, E. Yannaki, A. Anagnostopoulos, I. Sakellari
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000851560.91713.1c

Similar Items

Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation
by: Eleni Gavriilaki, et al.
Published: (2021-01-01)

P1311: LONG-TERM SAFETY AND EFFICACY OF EXTRACORPOREAL PHOTOPHERESIS AS EARLY SECOND-LINE TREATMENT FOR PATIENTS WITH STEROID-DEPENDENT OR REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE.
by: Eleni Gavriilaki, et al.
Published: (2023-08-01)

Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease
by: Eleni Gavriilaki, et al.
Published: (2024-09-01)

PB2261: DECREASE IN NEUTROPHIL-LYMPHOCYTE RATIO IMPACTS OVERALL SURVIVAL OF ADULT PATIENTS WITH HODGKIN LYMPHOMA AFTER ANTI-PD1 TREATMENT
by: Christos Varelas, et al.
Published: (2023-08-01)

Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change
by: Eleni Gavriilaki, et al.
Published: (2020-04-01)

Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation
by: Eleni Gavriilaki, et al.
Published: (2021-02-01)

Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity
by: Anastasia Papadopoulou, et al.
Published: (2021-08-01)

P1395: PENTAVALENT-SPECIFIC T-CELLS POST HAPLO-IDENTICAL TRANSPLANTATION FOR THE TREATMENT OF OPPORTUNISTIC INFECTIONS
by: Zoi Bousiou, et al.
Published: (2023-08-01)

Aplastic anemia and paroxysmal nocturnal hemoglobinuria in children and adults in two centers of Northern Greece
by: Eleni Gavriilaki, et al.
Published: (2022-11-01)

Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop?
by: Apostolia Papalexandri, et al.
Published: (2018-12-01)

PB2226: THE ROLE OF COMPLEMENT IN THE IMMUNE RESPONSE OF SICKLE CELL DISEASE PATIENTS AFER COVID-19 VACCINATION
by: C. Varelas, et al.
Published: (2022-06-01)

2183 Balancing patient-centeredness and patient safety in the hospitals: The case of pain care and patient satisfaction
by: Olena Mazurenko, et al.
Published: (2018-06-01)

Complement in Sickle Cell Disease: Are We Ready for Prime Time?
by: Varelas C, et al.
Published: (2021-03-01)

Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents
by: Maria Gavriilaki, et al.
Published: (2019-01-01)

Reinforcing the Immunocompromised Host Defense against Fungi: Progress beyond the Current State of the Art
by: Georgios Karavalakis, et al.
Published: (2021-06-01)

Real-world data of thrombotic microangiopathy management: The key role of ADAMTS13 activity and complement testing
by: Eleni Gavriilaki, et al.
Published: (2021-05-01)

P1698: INCREASED COMPLEMENT ACTIVATION AND DECREASED ADAMTS13 ACTIVITY IN PATIENTS WITH PRE-ECLAMPSIA COMPARED TO HEALTHY PREGNANCIES
by: T. M. Venou, et al.
Published: (2022-06-01)

Pharmacogenetic analyses of 2183 patients with advanced colorectal cancer; potential role for common dihydropyrimidine dehydrogenase variants in toxicity to chemotherapy
by: Madi, A, et al.
Published: (2018)

In vitro evidence of complement activation in patients with sickle cell disease
by: Eleni Gavriilaki, et al.
Published: (2017-12-01)

Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia
by: Eleni Gavriilaki, et al.
Published: (2018-10-01)

PB1894: NPM1 MUTATED ACUTE MYELOID LEUKEMIA: THE CO-MUTATION PATTERNS MAY BE ASSOCIATED WITH PROGNOSIS
by: Christos Varelas, et al.
Published: (2023-08-01)

Sirtuin1 activator SRT2183 suppresses glioma cell growth involving activation of endoplasmic reticulum stress pathway
by: Tian Ye, et al.
Published: (2019-07-01)

Cystic fibrosis mutations R1162X and 2183AA<FONT FACE=Symbol>®</FONT>G in two southern Brasilian states
by: Lilian Pereira, et al.
Published: (1999-09-01)

Neurologic complications after allogeneic transplantation: a meta‐analysis
by: Maria Gavriilaki, et al.
Published: (2019-10-01)

Pathogen-specific T Cells: Targeting Old Enemies and New Invaders in Transplantation and Beyond
by: Anastasia Papadopoulou, et al.
Published: (2023-01-01)

Cystic fibrosis in a boy with meconium ileus and mild clinical phenotype associated with 2183AA-G/D1152H genotype
by: Ebru Yalçin, et al.
Published: (2008-08-01)

PB2183: TRANSFUSION-RELATED COST OFFSETS AND TIME BURDEN IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH MOMELOTINIB (MMB) VS DANAZOL (DAN)
by: Lucia Masarova, et al.
Published: (2023-08-01)

A qualitative Design and optimization of CIGS-based Solar Cells with Sn2S3 Back Surface Field: A plan for achieving 21.83 % efficiency
by: Md. Ferdous Rahman, et al.
Published: (2023-12-01)

Change in Neurocognitive Function in Patients Who Receive CAR-T Cell Therapies: A Steep Hill to Climb
by: Evlampia Strongyli, et al.
Published: (2024-05-01)

Mengenalpasti faktor-faktor yang mempengaruhi pembelajaran fizik moden (SSF 2183) di kalangan pelajar KDPK sains sesi 1997/98 UTM /
by: 223579 Abd. Halim Ahmad Nawawi
Published: (1999)

Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
by: Eleni Gavriilaki, et al.
Published: (2019-02-01)

An Update in Drug-Induced Thrombotic Microangiopathy
by: Thomas Chatzikonstantinou, et al.
Published: (2020-05-01)

Robust SARS-COV-2-specific T-cell immune memory persists long-term in immunocompetent individuals post BNT162b2 double shot
by: Anastasia Papadopoulou, et al.
Published: (2022-07-01)

Mengenalpasti faktor-faktor yang mempengaruhi pembelajaran fizik moden (SSF 2183) di kalangan pelajar KDPK sains sesi 1997/98 UTM [microfilm] /
by: Abd. Halim Ahmad Nawawi
Published: (1999)

Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation.
by: Kharazi, S, et al.
Published: (2011)

Prospective study of complement activation and thromboinflammation within sickle cell disease and its complications
by: Christos Varelas, et al.
Published: (2024-07-01)

Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection
by: Eleni Gavriilaki, et al.
Published: (2022-06-01)

FLT3‐targeted therapy restores GATA1 pathway function in NPM1/FLT3‐ITD mutated acute myeloid leukaemia
by: D Sorcini, et al.
Published: (2023-11-01)

Gilteritinib as treatment for extra-medullary relapse of FLT3-ITD acute myeloid leukemia FLT3-ITD, after allogeneic haematopoietic stem cell transplantation
by: R. Iannotta, et al.
Published: (2022-01-01)

Natural Flt3Lg-Based Chimeric Antigen Receptor (Flt3-CAR) T Cells Successfully Target Flt3 on AML Cell Lines
by: Varvara Maiorova, et al.
Published: (2021-10-01)